US · Healthcare · Drug Manufacturers - Specialty & Generic
EPS came in at 1.53 against a street estimate of 1.62 — a miss of 5.6%.
Analysts rate Zoetis Inc a buy (12 buy, 8 hold, 0 sell out of 20) with an average price target of $111.94.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.49% |
| Vanguard Capital Management, LLC | 6.22% |
| Vanguard Portfolio Management, LLC | 5.72% |
| State Street Corp | 4.61% |
| State Farm Mutual Automobile Ins Co | 3.79% |
| Morgan Stanley - Brokerage Accounts | 3.37% |
| Geode Capital Management, LLC | 2.71% |
| Wellington Management Company LLP | 2.42% |
| Document | Date |
|---|---|
| Board / officer change · Q2 2026 | 2026-05-22 |
| Reg FD disclosure · Q2 2026 | 2026-05-20 |
| Quarterly report · Q1 2026 | 2026-05-07 |
| Results announced · Q2 2026 | 2026-05-07 |
| Proxy statement · Q4 2025 | 2026-04-08 |
| Annual report FY2025 | 2026-02-12 |
| Results announced · Q1 2026 | 2026-02-12 |
| Quarterly report · Q3 2025 | 2025-11-04 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.53 / share ex-date Jul 20, 2026 · pay Sep 1, 2026 | 2026-07-20 |
| Dividend | $0.53 / share ex-date Apr 20, 2026 · pay Jun 2, 2026 | 2026-04-20 |
| Dividend | $0.53 / share ex-date Jan 20, 2026 · pay Mar 3, 2026 | 2026-01-20 |
| Dividend | $0.50 / share ex-date Oct 31, 2025 · pay Dec 2, 2025 | 2025-10-31 |
| Dividend | $0.50 / share ex-date Jul 18, 2025 · pay Sep 3, 2025 | 2025-07-18 |
| Announcement | Date |
|---|---|
| Full year 2026 guidance provided following Q1 2026 results Zoetis Inc. filed an 8-K on May 7, 2026, announcing its first quarter 2026 financial results and providing full year 2026 guidance. This document itself contains no specific financial metric | 2026-05-07 |
| Financial results announced with full year 2026 guidance provided Zoetis Inc. announced its financial results for Q4 and full year 2025, along with 2026 guidance on February 12, 2026. However, this 8-K filing itself contains no actual financial data—it onl | 2026-02-12 |
| Q3 2025 results reported and full year 2025 guidance provided Zoetis Inc. filed an 8-K on November 4, 2025, announcing its third quarter 2025 financial results and updated full-year 2025 guidance. This is a routine earnings announcement filing. The 8-K | 2025-11-04 |
| Q2 2025 results reported and full year 2025 guidance provided Zoetis Inc. released its second quarter 2025 financial results on August 5, 2025. This 8-K filing is a standard regulatory announcement disclosing Q2 earnings and providing updated guidance | 2025-08-05 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Zoetis Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.